Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. (Q45390601)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 September 2008

Language	Label	Description	Also known as
English	Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.	scientific article published on 22 September 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

Mamoru Hasegawa

5

object named as

Mamoru Hasegawa

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Shuangqing Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Xia Feng

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tsugumine Shu

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tetsuro Matano

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Xiaoli Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hongtao Ma

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hongxia Li

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zelin Li

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Yi Zeng

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

22 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

6124-6131

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Strategies for an HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Sendai virus vectors as an emerging negative-strand RNA viral vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

A high-efficiency Cre/loxP-based system for construction of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Epitope dominance, competition and T cell affinity maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.09.017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45390601&oldid=1775329558"